In contrast to these findings, some studies have indicated that patients with HD do not exhibit an increased risk of diabetes and no significant differences in related metabolic indicators, histological manifestations, and insulin secretion levels were observed (Bacos et al., 2008; Boesgaard et al., 2009; Nambron et al., 2016). The gene discussed is INS; the disease is Huntington disease.